Cargando…

Myelofibrosis and Pancytopenia Associated With Primary Hyperparathyroidism

OBJECTIVE: Primary hyperparathyroidism (PHPT) has varied clinical presentations. Hematologic abnormalities secondary to PHPT have been described before. However, pancytopenia as the initial presentation has rarely been reported. We report a patient with PHPT who presented for evaluation of pancytope...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajan, Remya, Paul, Immanuel, Cherian, Kripa Elizabeth, Korula, Anu, Hephzibah, Julie, Manipadam, Marie Therese, Abraham, Deepak Thomas, Kapoor, Nitin, Paul, Thomas Vizhalil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association of Clinical Endocrinology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924162/
https://www.ncbi.nlm.nih.gov/pubmed/33851024
http://dx.doi.org/10.1016/j.aace.2020.11.018
_version_ 1783659032904466432
author Rajan, Remya
Paul, Immanuel
Cherian, Kripa Elizabeth
Korula, Anu
Hephzibah, Julie
Manipadam, Marie Therese
Abraham, Deepak Thomas
Kapoor, Nitin
Paul, Thomas Vizhalil
author_facet Rajan, Remya
Paul, Immanuel
Cherian, Kripa Elizabeth
Korula, Anu
Hephzibah, Julie
Manipadam, Marie Therese
Abraham, Deepak Thomas
Kapoor, Nitin
Paul, Thomas Vizhalil
author_sort Rajan, Remya
collection PubMed
description OBJECTIVE: Primary hyperparathyroidism (PHPT) has varied clinical presentations. Hematologic abnormalities secondary to PHPT have been described before. However, pancytopenia as the initial presentation has rarely been reported. We report a patient with PHPT who presented for evaluation of pancytopenia. METHODS: Histopathology of the bone marrow at presentation is described. Bone biochemistry results and the hematologic profile before and after curative parathyroidectomy are presented. RESULTS: A 48-year-old woman presented with pancytopenia (hemoglobin, 6.3 g/dL; total leucocyte count, 3000 cells/mm(3); and platelet count, 60 000 cells/mm(3)), and her bone marrow study showed marrow fibrosis. Biochemical evaluation revealed hypercalcemia (15.5 mg/dL), hypophosphatemia (2.2 mg/dL), and elevated total alkaline phosphatase (4132 U/L). Bone mineral density assessment by dual-energy X-ray absorptiometry scan revealed osteoporosis at all 3 sites, which was more severe in the distal one third of the forearm. Further investigations confirmed the diagnosis of PHPT (serum parathyroid hormone, 2082 pg/mL). Following curative parathyroidectomy, in addition to normalization of calcium, there was restoration of all 3 hematologic cell lines at 3 months. CONCLUSION: Pancytopenia may be a rare manifestation of PHPT. Thus, it may be prudent to evaluate the calcium profile in patients with chronic refractory anemia and pancytopenia.
format Online
Article
Text
id pubmed-7924162
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Association of Clinical Endocrinology
record_format MEDLINE/PubMed
spelling pubmed-79241622021-04-12 Myelofibrosis and Pancytopenia Associated With Primary Hyperparathyroidism Rajan, Remya Paul, Immanuel Cherian, Kripa Elizabeth Korula, Anu Hephzibah, Julie Manipadam, Marie Therese Abraham, Deepak Thomas Kapoor, Nitin Paul, Thomas Vizhalil AACE Clin Case Rep Case Report OBJECTIVE: Primary hyperparathyroidism (PHPT) has varied clinical presentations. Hematologic abnormalities secondary to PHPT have been described before. However, pancytopenia as the initial presentation has rarely been reported. We report a patient with PHPT who presented for evaluation of pancytopenia. METHODS: Histopathology of the bone marrow at presentation is described. Bone biochemistry results and the hematologic profile before and after curative parathyroidectomy are presented. RESULTS: A 48-year-old woman presented with pancytopenia (hemoglobin, 6.3 g/dL; total leucocyte count, 3000 cells/mm(3); and platelet count, 60 000 cells/mm(3)), and her bone marrow study showed marrow fibrosis. Biochemical evaluation revealed hypercalcemia (15.5 mg/dL), hypophosphatemia (2.2 mg/dL), and elevated total alkaline phosphatase (4132 U/L). Bone mineral density assessment by dual-energy X-ray absorptiometry scan revealed osteoporosis at all 3 sites, which was more severe in the distal one third of the forearm. Further investigations confirmed the diagnosis of PHPT (serum parathyroid hormone, 2082 pg/mL). Following curative parathyroidectomy, in addition to normalization of calcium, there was restoration of all 3 hematologic cell lines at 3 months. CONCLUSION: Pancytopenia may be a rare manifestation of PHPT. Thus, it may be prudent to evaluate the calcium profile in patients with chronic refractory anemia and pancytopenia. American Association of Clinical Endocrinology 2020-12-28 /pmc/articles/PMC7924162/ /pubmed/33851024 http://dx.doi.org/10.1016/j.aace.2020.11.018 Text en © 2020 AACE. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Rajan, Remya
Paul, Immanuel
Cherian, Kripa Elizabeth
Korula, Anu
Hephzibah, Julie
Manipadam, Marie Therese
Abraham, Deepak Thomas
Kapoor, Nitin
Paul, Thomas Vizhalil
Myelofibrosis and Pancytopenia Associated With Primary Hyperparathyroidism
title Myelofibrosis and Pancytopenia Associated With Primary Hyperparathyroidism
title_full Myelofibrosis and Pancytopenia Associated With Primary Hyperparathyroidism
title_fullStr Myelofibrosis and Pancytopenia Associated With Primary Hyperparathyroidism
title_full_unstemmed Myelofibrosis and Pancytopenia Associated With Primary Hyperparathyroidism
title_short Myelofibrosis and Pancytopenia Associated With Primary Hyperparathyroidism
title_sort myelofibrosis and pancytopenia associated with primary hyperparathyroidism
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924162/
https://www.ncbi.nlm.nih.gov/pubmed/33851024
http://dx.doi.org/10.1016/j.aace.2020.11.018
work_keys_str_mv AT rajanremya myelofibrosisandpancytopeniaassociatedwithprimaryhyperparathyroidism
AT paulimmanuel myelofibrosisandpancytopeniaassociatedwithprimaryhyperparathyroidism
AT cheriankripaelizabeth myelofibrosisandpancytopeniaassociatedwithprimaryhyperparathyroidism
AT korulaanu myelofibrosisandpancytopeniaassociatedwithprimaryhyperparathyroidism
AT hephzibahjulie myelofibrosisandpancytopeniaassociatedwithprimaryhyperparathyroidism
AT manipadammarietherese myelofibrosisandpancytopeniaassociatedwithprimaryhyperparathyroidism
AT abrahamdeepakthomas myelofibrosisandpancytopeniaassociatedwithprimaryhyperparathyroidism
AT kapoornitin myelofibrosisandpancytopeniaassociatedwithprimaryhyperparathyroidism
AT paulthomasvizhalil myelofibrosisandpancytopeniaassociatedwithprimaryhyperparathyroidism